Caveolin-3 deficiency decreases the gene expression level of osteopontin in mdx mouse skeletal muscle

Acta Myologica

Volumn 25, Issue 2, 2006, Pages 53-61

  Hagiwara, Yasuko ^a,b   Fujita, M ^a   Imamura, M ^a   Noguchi, S ^a   Sasaoka, T ^c  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^b MUSASHINO UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE FOR BASIC BIOLOGY   (Japan)

Author keywords

Caveolin 3; mdx mouse; Osteopontin

Indexed keywords

CAVEOLIN 3; DYSTROPHIN; MESSENGER RNA; OSTEOPONTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENE EXPRESSION; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; MOUSE; MUSCULAR DYSTROPHY; NONHUMAN; PATHOGENESIS; PROTEIN DEFICIENCY; SKELETAL MUSCLE; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

ANIMALS; CAVEOLIN 3; FEMALE; MALE; MICE; MICE, INBRED MDX; MUSCLE, SKELETAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOPONTIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 33947402695     PISSN: 11282460     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Tang ZL, Scherer PE, Okamoto T, et al. Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle. J Biol Chem 1996;271:2255-61.
2. Galbiati F, Razani B, Lisanti MP. Caveolae and caveolin-3 in muscular dystrophy. Trends Mol Med 2001;7:435-41.
3. Cohen AW, Hnasko R, Schubert W, et al. Role of caveolae and caveolins in health and disease. Physiol Rev 2003;84:1341-79.
4. Anderson R. The caveolae membrane system. Annu Rev Biochem 1998;67:199-225.
5. Minetti C, Sotgia F, Bruno C, et al. Mutations in the caveolin-3 gene cause an autosomal dominant limb-girdle muscular dystrophy. Nature Genet 1998;18:365-8.
6. Carbon I, Bruno C, Sotgia F, et al. Mutation in the CAV3 gene causes partial caveolin-3 deficiency and hyperCKemia. Neurology 2000;54:1373-6.
7. Merlini L, Carbone I, Capanni C, et al. Familial isolated hyperCKaemia associated with a new mutation in the caveolin-3 (CAV-3) gene. J Neurol Neurosurg Psychiatry 2002;73:65-7.
8. Alias L, Gallano P, Moreno D, et al. A novel mutation in the caveolin-3 gene causing familial isolated hyperCKaemia. Neuromuscul Disord 2004;14:321-4.
9. Betz RC, Schoser BG, Kasper D, et al. Mutations in CAV3 cause mechanical hyperirritability of skeletal muscle in rippling muscle disease. Nat Genet 2001;28:218-9.
10. Vorgerd M, Ricker K, Ziemssen F, et al. A sporadic case of rippling muscle disease caused by a de novo caveolin-3 mutation. Neurology 2001;57:2273-7.
11. Kubisch C, Schoser BG, von During M, et al. Homozygous mutations in caveolin-3 cause a severe form of rippling muscle disease. Ann Neurol 2003;53:512-20.
12. Yabe I, Kawashima A, Kikuchi S, et al. Caveolin-3 gene mutation in Japanese with rippling muscle disease. Acta Neurol Scand 2003;108:47-51.
13. Takeyama M, Aoki M, Nishino I, et al. Mutation in the caveolin-3 gene causes a peculiar form of distal myopathy. Neurology 2002;58:323-5.
14. Fisher D, Schroers A, Blumcke I, et al. Consequences of novel caveolin-3 mutation in a large German family. Ann Neurol 2003;53:233-41.
15. Hayashi T, Arimura T, Ueda K, et al. Identification and functional analysis of a caveolin-3 mutation associated with familial hypertrophic cardiomyopathy. Biochem Biophys Res Commun 2004;313:178-84.
16. Hagiwara Y, Sasaoka T, Araishi K, et al. Caveolin-3 deficiency causes muscle degeneration in mice. Hum Mol Genet 2000;9:3047-54.
17. Galbiati F, Engelman JA, Volonte D, et al. Caveolin-3 null mice show a loss of caveolae, changes in microdomain distribution of the dystrophin-glycoprotein complex, and T-tubule abnormalities. J Biol Chem 2001;276:21425-33.
18. Hoffman PE, Brown RH, Kunkel LM. Dystrophin: The protein product of the Duchenne muscular dystrophy. Cell 1987;51:919-28.
19. Arahata K, Ishiura S, Ishiguro T, et al. Immunostaining of skeletal and cardiac muscle surface membrane with antibody against Duchennne muscular dystrophy peptide. Nature 1988;333:861-3.
20. Bulfield G, Siller WG, Wright PA, Moore KJ. X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci USA 1984;81:1189-92.
21. Sicinski P, Geng Y, Ryder-Cook AS, et al. The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science 1989;244:1578-80.
22. Wells DJ, Wells KE. What do animal models have to tell us regarding Duchenne Muscular Dystrophy? Acta Myol 2005;25:172-80.
23. Dangain J, Vrbova G. Muscle development in mdx mutant mice. Muscle Nerve 1984;7:700-4.
24. Tanabe Y, Esaki K, Nomura T. Skeletal muscle pathology in X chromosome-linked muscular dystrophy (mdx) mouse. Acta Neuropathol 1986;69:91-5.
25. Haslett JN, Sanoudou D, Kho AT, et al. Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle. Proc Natl Acad Sci USA 2002;99:15000-5.
26. Porter JD, Khanna S, Kaminski HJ, et al. A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice. Hum Mol Genet 2002;11:263-72.
27. Noguchi S, Tsukahara T, Fujita M, et al. cDNA microarray analysis of individual Duchenne muscular dystrophy patients. Hum Mol Genet 2003;12:595-600.
28. Hirata A, Masuda S, Tamura T, Kai K, et al. Expression profiling of cytokines and related genes in regenerating skeletal muscle after cardiotoxin injection. Am J Pathol 2003;163:203-15.
29. O'Brien ER, Garvin MR, Stewart DK, et al. Osteopontin is synthesized by macrophage, smooth muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques. Arterioscler Thromb 1994;14:1648-56.
30. Imamura M, Araishi K, Noguchi S, Ozawa E. A sarcoglycan-dystroglycan complex anchors Dp116 and utrophin in the peripheral nervous system. Hum Mol Genet 2000;9:3091-100.
31. Amalfitana A, Chamberlain JS. The mdx-amplification-resistant mutation system assay, a simple and rapid polymerase chain reaction-based detection of the mdx allele. Muscle Nerve 1996;19:1549-53.
32. Hagiwara Y, Mizuno Y, Takemitsu M, et al. Dystrophin-positive muscle fibers following C2 myoblast transplantation into mdx nude mice. Acta Neuropathol 1995;90:592-600.
33. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;22:680-5.
34. Kyhse-Anderson J. Electroblotting of multiple gels: a sample apparatus without buffer tank for rapid transfer of proteins from polyacrylamide to nitrocellulose. J Biochem Biophys Methods 1984;10:203-9.
35. Hagiwara Y, Nishina Y, Yorifuji H, Kikuchi T. Immunolocalization of caveolin-1 and caveolin-3 in monkey skeletal, cardiac and uterine smooth muscles. Cell Struct Funct 2002;27:375-82.
36. Austyn JM, Gordon S. F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur J Immunol 1981;11:805-15.
37. Denhardt DT, Guo X. Osteopontin: a protein with diverse functions. FASEB J 1993;7:1475-82.
38. Kiss AL, Turi A, Mullner N, et al. Caveolae and caveolin isoforms in rat peritoneal macrophages. Micron 2002;33:75-93.
39. Kiss AL, Botos E, Turi A, et al. Ocadaic acid treatment causes tyrosine phosphorylation of caveolin-2 and induces internalization of caveolae in rat peritoneal macrophages. Micron 2004;35:707-15.
40. Gargalovic P, Dory L. Caveolin-1 and caveolin-2 expression in mouse macrophages. J Biol Chem 2001;276:26164-70.
41. Gargalovic P, Dory L. Cellular apoptosis is associated with increased caveolin-1 expression in macrophages. J Lipid Res 2003;44:1622-32.
42. Giachelli C, Lombardi D, Johnson RJ, et al. Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. Am J Pathol 1998;152:353-8.
43. Sotgia F, Lee JK, Das K, et al. Caveolin-3 directly interacts with the C-terminal tail of beta-dystroglycan. Identification of central WW-like domain within caveolin family members. J Biol Chem 2000;275:38048-58.
44. Akiyama C, Kobayashi S, Nonaka I. Comparison of behavior in muscle fiber regeneration after bupivacaine hydrochloride and acid anhydride-induced myonecrosis. Acta Neuropathol 1992;83:584-9.
45. Lescaudron L, Peltekian E, Fontaine-Perus J, et al. Blood borne macrophages are essential for the triggering of muscle regeneration following muscle transplant. Neuromuscul Disord 1999;9:72-80.
46. Cantini M, Massimino ML, Bruson A, et al. Macrophages regulate proliferation and differentiation of satellite cells. Bioch Biophys Res Comm 1994;202:1688-96.
47. Merly F, Lescaudron L, Rouaud T, et al. Macrophages enhance muscle satellite cell proliferation and delay their differentiation. Muscle Nerve 1999;22:724-32.